Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000912282-12-000575
Filing Date
2012-06-28
Accepted
2012-06-28 16:53:32
Documents
9
Period of Report
2012-06-26

Document Format Files

Seq Description Document Type Size
1 oncolytics6k_06262012.htm 6-K 25284
2 FINAL SCRUITINEER'S REPORT FOR ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS HELD O ex99_1.htm EX-99.1 6624
3 oncorpt_p0.jpg GRAPHIC 26611
4 oncorptp1.jpg GRAPHIC 55373
5 oncorpt_p2.jpg GRAPHIC 58402
6 oncorpt_p3.jpg GRAPHIC 55441
7 oncorpt_p4.jpg GRAPHIC 45075
8 oncorpt_p5.jpg GRAPHIC 58030
9 oncorpt_p6.jpg GRAPHIC 24315
  Complete submission text file 0000912282-12-000575.txt   479139
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 12933120
SIC: 2834 Pharmaceutical Preparations